
|Articles|July 7, 2003
Drug errors associated with opium tincture and paregoric
FDA will require new labeling for Opium Tincture and Paregoric, which have been associated with several drug errors.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
3
Meta-Analysis Identifies 5 Risk Factors for Post-COVID-19 Condition
4
Wicked Good Cardiometabolic Chat: Once-Weekly Insulin Management
5







































